L’apyrexie comme indicateur de suivi des cas de tuberculose à bacilloscopie positive et négative traités à Cotonou
Résumé
Texte intégral :
PDFRéférences
Remus N, Fieschi C, Alcaïs A, Delacourt C, Casanova J L, Abel L. Prédisposition mendélienne à la tuberculose. Revue française d’allergologie et d’immunologie clinique 2005, 45 : 571-575
World Health Organization. Global tuberculosis report 2017. Geneva, Switzerland; 2017. [http://www.who.int/iris/handle/10665/250441]. Consulté le 23 Juin 2017 à 23h543. Programme national contre la tuberculose. Guide du programme national contre la tuberculose au Bénin. 4ème Edition. Cotonou: PNT; 2017; 78. Disponible : http://www.pnt-benin.org/wpcontent/uploads/2019/02/Benin_Guide-PNT.pdf4. Yassin Z, Ahmadinejad Z, Kouchak HE. The Fever Response after Treatment of Tuberculosis: What is the expected time and what are the risk Factors. J Infec Dis Treat 2016, 2: 15. Ba Diallo A. Performance du GeneXpert MTB/RIF® dans le diagnostic de la tuberculose extrapulmonaire à Dakar : 2010-2015. Pan African Medical Journal 2016, 25 : 1296. Feleke BE, Alene GD, Feleke TE. Clinical response of tuberculosis patients, a prospective cohort study. PLoS ONE 2018, 13(1): 1-117. Moreno S, Baraia J, Parras F. Fever Evolution after Treatment in Patients with Tuberculosis and HIV Infection. Rev Clin Esp 1995, 195:150-1538. Kiblawis SS, Jay SJ, Stonehill RB, Norton J. Fever response of patients on therapy for pulmonary tuberculosis. Am Rev Respir Dis 1981: 123: 20-249. Barnes PF, Chan LS, Wong SF. The course of fever during treatment of pulmonary tuberculosis. Tubercle 1987, 68: 255-26010. Afework K, Getahun M, Belete A, Ermias D, Firew M, Dereje K. Coinfection and clinical manifestations of tuberculosis in human immunodeficiency virus infected and uninfected adults at a teaching hospital, northwest Ethiopia. J Microbiol immunol infect 2007, 40:116-12211. Tsao TC, Tsai YH, Lan RS, Shieh WB, Lee CH. Fever Characteristics in Tuberculosis, Clinical Observations in 597 Cases. Changgeng yi xueza zhi 1989, 12: 81-8812. Faure S. Antituberculeux. Actualités pharmaceutiques 484 (2009) : 45-813. Wallaert B. Epanchement pleural liquidien. Référentiel de sémiologie respiratoire 2017, 89-9214. Barakat MT. Persistant fever in pulmonary tuberculosis. BMJ 1996, 313: 154315. Breen R A M, Smith C J, Bettinson H. Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax 2004, 59 : 704-707
Renvois
- Il n'y a présentement aucun renvoi.